Coherus Oncology, Inc. (CHRS)

Coherus Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	179.75	28.51	-237.89	-291.75	-287.1	132.24
Depreciation & Amortization	4.64	5.28	3.79	3.7	3.45	2.89
Stock-Based Compensation	24.05	27.8	43.11	50.74	51.36	38.16
Other Adjustments	-339.1	-137.92	52.93	75.45	152.49	15.5
Change in Receivables	170.29	149.35	-150.66	13.05	34.06	-15.22
Changes in Inventories	-31.57	-31.65	-46.72	-47.25	-6.25	-38.36
Changes in Accounts Payable	-43.18	-3.94	23.76	-4.54	0.87	-9.82
Changes in Accrued Expenses	-30.08	-62.35	5.44	2.09	17.7	11.21
Changes in Other Operating Activities	0.43	-63.81	136.29	-42.2	-4.03	-9.25
Operating Cash Flow	-105.87	-20.44	-174.88	-241.12	-37.43	154.15
Operating Cash Flow Growth	-	-	-	-	-	443.63%
Capital Expenditures	-	-	-	-	-1.29	-7.23
Sale of Property, Plant & Equipment	-	-	-	-	-	0.18
Purchases of Investments	-	-	-19.51	-127.38	-182.49	-273.85
Proceeds from Sale of Investments	-	14.89	157.64	-	181.36	274
Proceeds from Business Divestments	-	227.82	-	-	-	-
Other Investing Activities	-0.4	-12.39	-0.49	-39.47	-136	-7.5
Investing Cash Flow	445.05	230.32	144.64	-166.85	-138.41	-14.4
Long-Term Debt Issued	-	36.98	-	240.68	-	222.16
Long-Term Debt Repaid	-	-260.39	-	-190.75	-	-
Net Long-Term Debt Issued (Repaid)	-	-223.41	-	49.93	-	222.16
Issuance of Common Stock	-	2.67	74.22	9.37	54.3	21.23
Net Common Stock Issued (Repurchased)	-	2.67	74.22	9.37	54.3	21.23
Other Financing Activities	-0.3	33.76	-4.62	-4.97	-2.43	-19.44
Financing Cash Flow	-281.72	-186.97	69.6	54.33	51.88	223.95
Net Cash Flow	57.46	22.91	39.36	-353.65	-123.96	363.69
Beginning Cash & Cash Equivalents	159.69	103.34	63.99	417.64	541.6	177.91
Ending Cash & Cash Equivalents	217.16	126.25	103.34	63.99	417.64	541.6
Free Cash Flow	-105.87	-20.44	-174.88	-241.12	-38.72	146.91
Free Cash Flow Growth	-	-	-	-	-	453.70%
FCF Margin	-74.15%	-7.66%	-67.98%	-114.25%	-11.86%	30.88%
Free Cash Flow Per Share	-0.99	-0.18	-1.86	-3.11	-0.51	1.76
Levered Free Cash Flow	-252.32	-351.37	-115.33	-330.03	-276.64	303.83
Unlevered Free Cash Flow	-239.31	-268.14	-80.32	-345.08	-253.4	101.76

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q